Cargando…
Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis
Human papillomavirus (HPV) induced cervical cancer is the second most common cause of death, after breast cancer, in females. Three prophylactic vaccines by Merck Sharp & Dohme (MSD) and GlaxoSmithKline (GSK) have been confirmed to prevent high-risk HPV strains but these vaccines have been shown...
Autores principales: | Jabbar, Basit, Rafique, Shazia, Salo-Ahen, Outi M. H., Ali, Amjad, Munir, Mobeen, Idrees, Muhammad, Mirza, Muhammad Usman, Vanmeert, Michiel, Shah, Syed Zawar, Jabbar, Iqra, Rana, Muhammad Adeel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305797/ https://www.ncbi.nlm.nih.gov/pubmed/30619353 http://dx.doi.org/10.3389/fimmu.2018.03000 |
Ejemplares similares
-
Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins
por: Usman Mirza, Muhammad, et al.
Publicado: (2016) -
Erratum: Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins
por: Mirza, Muhammad Usman, et al.
Publicado: (2017) -
An Immunoinformatics Approach to Design a Potent Multi-Epitope Vaccine against Asia-1 Genotype of Crimean–Congo Haemorrhagic Fever Virus Using the Structural Glycoproteins as a Target
por: Shah, Syed Zawar, et al.
Publicado: (2022) -
In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors
por: Mirza, Muhammad Usman, et al.
Publicado: (2019) -
Inhibition of Oncogenic Kinases: An In Vitro Validated Computational Approach Identified Potential Multi-Target Anticancer Compounds
por: Ikram, Nazia, et al.
Publicado: (2019)